| | COVID-19 clinical operations
ICON has adopted numerous measures to protect the welfare of patients, to protect the safety of our employees and to ensure the continuity of your research programmes during COVID-19. Learn more about how to keep your trial on track in this evolving environment.
|
Today's Rundown Sanofi CEO: Up-front funding wins U.S. first access to coronavirus shot Mount Sinai launches post-COVID-19 care center for ongoing treatments, research Thermo Fisher, WuXi and Mayo Clinic to develop open-platform COVID-19 antibody test With capacity stretched and billions of doses required, COVID-19 vaccine makers cheer each other on Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall Healthcare roundup: Aetna extends COVID cost-sharing waivers; Faulkner says Epic working on immunity passport tech Biopharma roundup: U.S. has rights to ‘largest pre-order’ of vaccine, Sanofi CEO says AHIP wants payers to offer a grace period for any surgeries canceled or postponed due to COVID-19 To screen COVID-19 patients for heart problems, FDA clears several ultrasound, AI devices from Philips, Eko, Caption Health Wellcome Leap nabs $300M, ex-DARPA, Illumina execs to battle global health problems KFF: More than 20M of newly unemployed could qualify for ACA tax credits Featured Story | | | Wednesday, May 13, 2020 As questions swirl over equitable access to COVID-19 vaccines, Sanofi CEO Paul Hudson has laid out some of his company’s plans should its program succeed, Bloomberg reports. A key point? The U.S. will be first in line. |
|
|---|
|
Top Stories Wednesday, May 13, 2020 Mount Sinai Health System is launching a new Center for Post COVID Care to offer additional support for and gather crucial data from patients recovering from the virus as they transition from hospital to home. Wednesday, May 13, 2020 Thermo Fisher Scientific is developing its own COVID-19 antibody test through an ongoing, three-way collaboration with WuXi Diagnostics and the Mayo Clinic, and plans to seek international authorizations for the test over the next few weeks. Wednesday, May 13, 2020 No one company can provide enough COVID-19 vaccine doses for the world, Moderna Therapeutics CEO Stephane Bancel says. As he and his fellow aspirants think ahead to a global rollout—and advance various ideas for allocating doses—it's becoming clear we'll need several pandemic-fighting vaccines to win approval and share the load. Wednesday, May 13, 2020 U.S. Big Pharma Pfizer and German biotech partner BioNTech are looking to ramp up trials of its vaccines against COVID-19 with a major scaled-up test plotted for the fall. Wednesday, May 13, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Wednesday, May 13, 2020 Sanofi will distribute the first doses of a potential COVID-19 vaccine to the U.S. after the government stepped up to invest in the drugmaker's research. Wednesday, May 13, 2020 America’s Health Insurance Plans urged insurers to offer a grace period for any pre-authorized surgeries and procedures canceled due to COVID-19 as health systems seek to restart. Wednesday, May 13, 2020 To help detect and diagnose cardiac complications, the FDA authorized devices and algorithms from Philips, Eko and Caption Health this week—which are also, in part, designed to help limit healthcare providers’ exposure to COVID_19. Tuesday, May 12, 2020 The U.K.’s Wellcome Trust has spun out a new nonprofit with a hefty seed fund and some big names to battle against “the most pressing global health challenges of our time.” Wednesday, May 13, 2020 As unemployment continues to skyrocket due to COVID-19, a new analysis from the Kaiser Family Foundation shows more than 20 million people losing job-based insurance could qualify for ACA tax credits to lower the cost of insurance. |
